Krystal Biotech (KRYS) Inventory Average (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Inventory Average data on file, last reported at $41.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 47.25% year-over-year to $41.6 million; the trailing twelve-month figure through Mar 2026 stood at $41.6 million (up 47.25% YoY), and the FY2025 full-year result was $33.5 million, up 99.99% from the prior year.
• Inventory Average climbed to $41.6 million in Q1 2026, from $39.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $41.6 million in Q1 2026 to a low of $6.1 million in Q4 2023.
• A 4-year average of $23.8 million and a median of $25.4 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 267.68% in 2024 and soared 47.25% in 2026, its largest moves.
• Tracing KRYS's Inventory Average over 4 years: stood at $6.1 million in 2023, then jumped by 267.68% to $22.5 million in 2024, then surged by 73.23% to $39.1 million in 2025, then advanced by 6.42% to $41.6 million in 2026.
• Business Quant data shows KRYS's Inventory Average at $41.6 million in Q1 2026, $39.1 million in Q4 2025, and $34.3 million in Q3 2025.